[HTML][HTML] ABC of obesity: obesity and vascular disease

DA Lawlor, M Lean, N Sattar - BMJ: British Medical Journal, 2006 - ncbi.nlm.nih.gov
Previous articles in this series have discussed the relation of overweight and obesity with
coronary heart disease (CHD) and individual cardiovascular disease risk factors—such as …

[HTML][HTML] Impact of overweight/obesity on clinical outcomes of patient with vasospastic angina: from the vasospastic angina in Korea registry

MH Lee, SH Jo, S Kwon, BW Park, DW Bang… - Scientific Reports, 2020 - nature.com
Obesity is associated with a high risk of morbidity and mortality in the general population
and is a major independent risk factor for cardiovascular disease. We sought to evaluate the …

Obesity and prognosis-just one of many cardiovascular paradoxes?

CJ Lavie - Progress in cardiovascular diseases, 2014 - pubmed.ncbi.nlm.nih.gov
Obesity and prognosis-just one of many cardiovascular paradoxes? Obesity and prognosis-just
one of many cardiovascular paradoxes? Prog Cardiovasc Dis. 2014 Jan-Feb;56(4):367-8. doi …

An update on dapagliflozin for the treatment of heart failure.

B Akinci - Drugs of Today (Barcelona, Spain: 1998), 2021 - europepmc.org
Heart failure (HF) is a substantial source of morbidity and mortality. Several clinical trials
have reported a significant HF benefit of sodium/glucose cotransporter 2 (SGLT2) inhibitors …

Impact of body mass index on long‐term clinical outcomes after second‐generation drug eluting stent implantation: Insights from the international global RESOLUTE …

R Diletti, HM Garcia‐Garcia… - Catheterization and …, 2015 - Wiley Online Library
Background An increased body mass index (BMI) is associated with a high risk of
cardiovascular disease and reduction in life expectancy. However, several studies reported …

A nomogram based on systemic inflammation markers can predict adverse outcomes in patients with heart failure

Z Liu, X Zhou - Nan Fang yi ke da xue xue bao= Journal of …, 2022 - europepmc.org
Objective To construct a nomogram based on systemic inflammation markers for assessing
the risk of adverse outcomes in patients with heart failure (HF). Methods We retrospectively …

Cholesterol and chloride in acute heart failure

B Radulović, I Potočnjak, S Dokoza Terešak… - Acta clinica …, 2019 - hrcak.srce.hr
Sažetak Detecting predictors of poor outcome is crucial for understanding the underlying
pathophysiology of heart failure (HF) and thus creating new therapeutic concepts. It is well …

The effect of hemodialysis-induced preload changes on the left ventricular function: A speckle-tracking echocardiographic study

AA Emara, MA Koura, M Kamel… - Menoufia Medical …, 2016 - menoufia-med-j.com
Objective: This study aim to evaluate the effect of hemodialysis (HD)-induced preload
changes on the left ventricular (LV) function in patients with chronic renal failure using LV …

Obesity Paradox"–another look at the problem of cardiovascular disease

OV Shpagina, IZ Bondarenko - Obesity and metabolism, 2013 - omet-endojournals.ru
Major epidemiologic studies over the last century demonstrated that obesity leads to several
severe diseases such as diabetes mellitus, hypertension, coronary heart disease, chronic …

Molecular insights into appetite control and neuroendocrine disease as risk factors for chronic diseases in Western countries

IJ Martins, R Creegan, WLF Lim, R Martins - 2013 - ro.ecu.edu.au
Environmental factors such as stress, anxiety and depression are important to consider with
the global increase in chronic diseases such as cardiovascular diseases, cancer, stroke …